Palantir Stock Faces Government-Contract Risk Amid AI Growth

Palantir stock posted a Q3 beat and robust margins but government reliance and $10B Army framework make the Feb. 2, 2026 Q4 report a positioning test.

January 21, 2026·2 min read
View all news articles
Flat filled vector of a server rack with a fractured casing showing government contract risk and AI growth for Palantir stock

KEY TAKEAWAYS

  • Q3 revenue beat at $1.18 billion with EPS $0.21, topping expectations.
  • Government sales were about 54% of revenue and a $10 billion, 10-year Army framework heightened recognition risk.
  • Q4 report on Feb. 2, 2026 will test whether commercial AI momentum offsets government concentration.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Palantir stock is under investor scrutiny after a quarter that beat expectations and showed robust margins, while heavy government revenue and a decade-long Army framework raise questions ahead of the company's Q4 report scheduled for Feb. 2, 2026.

Quarterly Results and Financials

Palantir Technologies (PLTR) reported Q3 2025 revenue of $1.18 billion, exceeding the $1.09 billion consensus, with earnings per share of $0.21 versus $0.17 expected. Trailing 12 months, the company recorded $3.9 billion in revenue, $1.1 billion in net income, and $0.43 in EPS. It held $3.9 billion in cash and short-term investments at quarter-end.

Profitability remained strong, with gross margins near 80% on a trailing basis and a Rule-of-40 score of 114% in the last quarter. Commercial momentum accelerated as U.S. commercial revenue rose roughly 121% year-over-year, and the customer count increased 69% to 593, signaling expanding adoption beyond the public sector.

Contracts Growth and Risks

Government sales accounted for about 54% of the quarter’s revenue and grew approximately 52% year-over-year, highlighting the company’s heavy public-sector reliance. In early August 2025, Palantir secured a consolidated U.S. Army framework valued at $10 billion over 10 years. It also holds a separate $30 million contract with ICE and a UK defense engagement worth £1.5 billion signed in September 2025.

The decade-long Army framework may cause uneven revenue recognition, creating near-term timing uncertainty. The company expects commercial revenue to grow at least 68% in the coming quarter, implying a step-up to about $1.178 billion. Its longer-term projections target revenue rising toward $11.9 billion by 2030, with EPS climbing to $1.44.

Analysts remain divided on valuation. Price targets range widely from low levels up to $255, with medians near $190–$200. Recommendations split between Hold and Buy, while forward price-to-sales multiples exceed 100 times. Disclosed short positions, including one filed during the Q3 period by Michael Burry, add to trading interest. Institutional ownership stands at about 56%.

Bulls cite Palantir’s AI platform and high margins as a foundation for scaling. Bears point to concentrated government exposure, stretched valuation multiples, and recognition risks from large, multi-year contracts.

The upcoming Q4 report will test whether accelerating commercial growth and strong unit economics can offset government concentration and valuation concerns, making it a key near-term catalyst for the stock.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Nvidia Stock Draws Investor Attention on AI

Nvidia Stock Draws Investor Attention on AI

Nvidia stock drew investor focus after a sharp revenue surge as its AI infrastructure leadership drove flows and attention toward hardware suppliers.

Zoox Robotaxi Expansion Moves Into Phoenix, Dallas

Zoox Robotaxi Expansion Moves Into Phoenix, Dallas

Zoox robotaxi expansion adds Phoenix and Dallas and a Scottsdale Fusion Center, widening U.S. testing and sharpening investor focus on AV scaling.

Anthropic Sues DoD Over Supply-Chain Risk

Anthropic Sues DoD Over Supply-Chain Risk

Anthropic sues DoD to block a supply-chain risk designation and raises procurement questions that could complicate Claude access for defense contracts.

Oil Prices Surge After Middle East Strikes

Oil Prices Surge After Middle East Strikes

Oil prices surge after Middle East strikes and Gulf shipping disruptions drove a Brent crude rally that heightened supply and inflation risks for traders.

Live Nation Settlement Reached With DOJ

Live Nation Settlement Reached With DOJ

Live Nation settlement with the DOJ would force divestitures, open Ticketmaster to rivals and impose about $200 million in damages, pressuring fee income.

Hims & Hers Novo Nordisk Partnership Reported

Hims & Hers Novo Nordisk Partnership Reported

Reports say Hims & Hers Novo Nordisk partnership would let Hims sell Wegovy and Ozempic via telehealth and could alter revenue mix and positioning.